Navigation Links
Urinary tract infections steal from hosts' defense arsenals
Date:7/8/2012

Humans have known for centuries that copper is a potent weapon against infection. New research shows that the bacteria that cause serious urinary tract infections "know" this, too, and steal copper to prevent the metal from being used against them.

Blocking this thievery with a drug may significantly improve patients' chances of fighting off infections, according to researchers at Washington University School of Medicine in St. Louis. The findings appear online July 8 in Nature Chemical Biology.

In the United States alone, annual treatment costs for urinary tract infections are estimated to run as high as $1.6 billion. Most urinary tract infections are caused by Escherichia coli (E. coli).

"While some patients are able to clear these infections without issue, in others the infection persists or recurs despite antibiotic therapy," says senior author Jeff Henderson, MD, PhD, assistant professor of medicine and of molecular microbiology. "In some cases, the infection spreads to the kidney or the blood and becomes life-threatening. We've been investigating what's different about the bacteria that cause these more troublesome infections."

Scientists have known for years that E. coli makes a molecule called yersiniabactin that takes iron from host cells. The bacteria need the iron to grow and reproduce.

In earlier research, Henderson found that the E. coli that cause serious infections are more likely to make yersiniabactin. This finding and the fact that E. coli already produce another molecule that steals iron led Henderson and Kaveri Chaturvedi, a student in his laboratory, to suspect that the bacterium might be using yersiniabactin for other purposes.

To test the theory, the researchers put yersiniabactin in urine samples from healthy patients. They found the molecule bound iron as expected but also picked up copper. Next, they conducted the same analysis in samples from patients with urinary tract infections who were treated at the University of Washington in Seattle.

"We found copper bound to yersiniabactin in nearly every patient whose bacteria made the molecule," Henderson says. "Yersiniabactin was often bound to copper more than it was to iron."

When researchers put E. coli in the same test tube with copper, the bacteria that made yersiniabactin were more likely to survive.

Copper's microbe-fighting properties were recognized long before scientists had described the microbes that cause infection. Ancient Greeks and Egyptians knew that treating wounds with copper improved the healing process.

Modern researchers have two explanations for copper's anti-microbial effects: the metal can stimulate production of other chemically reactive molecules that damage bacteria; and it is also directly toxic to the bacteria.

Henderson, who treats patients with urinary tract infections at Barnes-Jewish Hospital, is currently studying whether the presence or absence of yersiniabactin can help physicians assess an infection's chances of becoming more serious.

He and his colleagues are also looking at other disease-causing bacteria that make yersiniabactin to see if they use it in a fashion similar to the E. coli that cause urinary tract infections.


'/>"/>

Contact: Michael C. Purdy
purdym@wustl.edu
314-286-0122
Washington University School of Medicine
Source:Eurekalert

Related biology news :

1. Beehive extract shows potential as prostate cancer treatment
2. Bigger gorillas better at attracting mates and raising young
3. Mainz University Medical Center attracts funding of Alexander von Humboldt Professorship
4. Unexpected discovery reveals a new mechanism for how the cerebellum extracts signal from noise
5. Pycnogenol (French maritime pine bark extract) shown to improve menopause symptoms in new study
6. Toward an alternative for antibiotics to fight bacterial infections?
7. Innate immune system protein provides a new target in war against bacterial infections
8. Vitamin D supplements may protect against viral infections during the winter
9. To drive infections, a hijacking virus mimics a cells signaling system
10. Stealthy microscopy method visualizes E. coli sub-cellular structure in 3-D
11. Stealing lifes building blocks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2016)... , June 9, 2016 ... Police deploy Teleste,s video security solution to ensure the safety ... France during the major tournament Teleste, ... communications systems and services, announced today that its video security ... to back up public safety across the country. ...
(Date:6/2/2016)... 2, 2016   The Weather Company , an IBM ... an industry-first capability in which consumers will be able to ... ask questions via voice or text and receive relevant information ... Marketers have long sought an advertising solution that ... be personal, relevant and valuable; and can scale across millions ...
(Date:5/20/2016)... May 20, 2016  VoiceIt is excited to ... VoicePass. By working together, VoiceIt and ... VoiceIt and VoicePass take slightly different approaches to ... both security and usability. ... this new partnership. "This marketing and ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
Breaking Biology Technology: